April 11, 2017 / 11:17 AM / 6 months ago

BRIEF-GSK makes changes to financial reporting; sees growth in emerging markets

April 11 (Reuters) - GlaxoSmithKline Plc:

* Change to financial reporting framework

* As a result of its latest review, GSK will be making following change to its financial reporting from Q1 2017.

* Core results will be renamed adjusted results and will include ‘ordinary course’ legal charges

* From Q1 2017, only significant legal charges and expenses will be excluded in order to present adjusted results.

* Change is not expected to affect group’s previously announced guidance for 2017 or group’s outlook for five-year period 2016-2020

* Target expectation of at least 6 bln stg of revenue/ year on a CER basis by 2020 from products launched since 2013 is now expected to be met up to 2 yrs earlier

* Expects volume demand for its products to increase, particularly in emerging markets Source text for Eikon: Further company coverage: (Bengaluru Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below